Surrey Heartlands

Joint Formulary & PAD

Ofatumumab - Multiple sclerosis

You are here : Home > Formulary Search > Ofatumumab - Multiple sclerosis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Subcutaneous injection (sc)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
NHSE
NICE
Restrictions / Comments :
Important

ASPH are the only Surrey Heartlands Trust commissioned to provide this.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Ofatumumab
Indication :
Multiple sclerosis
Group Name :
Keywords :
MS
Brand Names Include :
Kesimpta
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Ofatumumab is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Multiple sclerosis.

Committee Recommendations (1)

02 Apr 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.